Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Objective<p>Silicosis is characterized by silicon nodules and diffuse pulmonary fibrosis. To date, no effective therapy has been developed for the treatment of silicosis. This study aimed to investigate the effects of Galunisertib, a TGF-β receptor I kinase inhibitor, on the autophagy-lysosome...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Rou Li (11575418) (author)
Otros Autores: Huimin Kang (435951) (author), Aoxiang Hu (22679153) (author), Guo Chen (182090) (author), Tinghua Yan (18786622) (author), Ting Liu (45625) (author), Shi Chen (120917) (author)
Publicado: 2025
Materias:
Pharmacology
Galunisertib
silicosis
TGF-β
autophagy
fibrosis
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares